Nanoparticle-Based Drug Delivery Systems for Local Anesthesia

Nanoparticle-based systems for local anaesthesia harness submicrometre carriers to deliver anaesthetic agents directly to peripheral nerves or tissue sites, thereby prolonging analgesic effect while minimising systemic exposure. Common platforms include lipid vesicles, polymeric matrices, nanocrystals and hybrid nanogels, each engineered to encapsulate hydrophobic or hydrophilic agents such as bupivacaine, ropivacaine and tetrodotoxin. By controlling particle size, surface chemistry and material composition, these systems achieve sustained release, targeted deposition and stimuli-responsive on-demand drug liberation. Benefits encompass reduced peak plasma levels, lower toxicity, improved patient comfort and diminished reliance on opioids. Contemporary research addresses challenges in drug loading, burst release, biocompatibility and scalability, with an emphasis on clinical translation for postoperative pain management, dental procedures and minor surgical interventions worldwide.

Research from Nature Portfolio

Recent studies have introduced aromatic-modified liposomes containing covalently attached hydrophobic moieties within phospholipid bilayers, markedly enhancing loading of small hydrophilic anaesthetics and suppressing premature release. Application to tetrodotoxin demonstrated extended blockade duration with reduced systemic toxicity, representing a leap forward in liposomal design. In parallel, photo-activated macromolecular prodrugs have been devised by linking tetracaine to thermo-gel forming polymers via light-sensitive cleavable bonds. This approach enables injectable solutions that solidify at body temperature and release anaesthetic only upon blue-light illumination, allowing clinicians to titrate onset and intensity of anaesthesia in real time without systemic side effects.

Nanoparticle-Based Drug Delivery Systems for Local Anesthesia publication trend

The graph below shows the total number of articles in nanoparticle-based drug delivery systems for local anesthesia across all publications each year (not limited to Nature Index journals).

Technical terms

Liposome: Spherical vesicle composed of lipid bilayers for encapsulating both hydrophilic and hydrophobic drugs.

Polymeric nanoparticle: Solid colloidal particle formed from biodegradable polymers, providing controlled drug release.

Nanogel: Crosslinked hydrogel nanoparticle that swells or contracts in response to environmental stimuli to regulate drug release.

Stimuli-responsive: Material property enabling cargo release triggered by external cues such as light, temperature or pH.

Macromolecular prodrug: Conjugate of an active drug and a polymer backbone, releasing the drug upon chemical or physical trigger.

Encapsulation efficiency: Percentage of drug successfully loaded into a carrier relative to the total amount used in formulation.

References

1. Aromatized liposomes for sustained drug delivery. Nature Communications (2023).
2. Light-triggered release of conventional local anesthetics from a macromolecular prodrug for on-demand local anesthesia. Nature Communications (2020).
3. Size control of ropivacaine nano/micro-particles by soft-coating with peptide nanosheets for long-acting analgesia. Theranostics (2024).
4. Nanogels with High Loading of Anesthetic Nanocrystals for Extended Duration of Sciatic Nerve Block. ACS Applied Materials & Interfaces (2021).
5. Advances of Nano-Structured Extended-Release Local Anesthetics. Discover Nano (2020).